RMC-5127

N/A

Report date: 2026/01/19 20:02:34
NME

Base Information

Drug NameRMC-5127
Drug Alias NameRMC-5127
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12V inhibitors
TargetsKRAS G12V
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRevolution Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevolution Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A